Skip to content
OpenCapital
Collapse sidebar
Watchlist
Screener
Filings
Earnings
Charts
Collapse sidebar
Screener
MapLight Therapeutics, Inc.
MPLT
Return on equity
Return on equity at other companies
Bristol-Myers Squibb
BMY
46.7%
+17.8pp
Johnson & Johnson
JNJ
25.7%
-4.5pp
Neurocrine Biosciences
NBIX
22.5%
+10.1pp
Acadia Pharmaceuticals
ACAD
35.7%
+2.6pp
AbbVie
ABBV
89%
+32.7pp
Rapport Therapeutics, Inc.
RAPP
-40%
+22.3pp
Other financials
Income statement
See full
Operating income
-$64.5M
-174%
Net income
-$60.7M
-172%
EPS (diluted)
-$1.34
+95.4%
Balance sheet
See full
Cash & equivalents
$55.7M
—
Total debt
$5.6M
—
Total equity
$399.8M
+285%
Total assets
$418.8M
—
Cash flow
See full
Operating cash flow
-$51.2M
-100%
CapEx
$24.0K
—
Free cash flow
-$51.2M
—
Valuation
See full
Market cap
$602.19M
-13.2%
Enterprise value
$552.07M
—
Returns & leverage
See full
Debt / equity
0×
—
Current ratio
22.9×
—
Watchlist
Screener
Filings
Earnings
Charts